Landiolol
-
Landiolol
structure -
-
CAS No:
133242-30-5
-
Formula:
C25H39N3O8
-
Chemical Name:
Landiolol
-
Synonyms:
Benzenepropanoic acid,4-[(2S)-2-hydroxy-3-[[2-[(4-morpholinylcarbonyl)amino]ethyl]amino]propoxy]-,[(4S)-2,2-dimethyl-1,3-dioxolan-4-yl]methyl ester;Benzenepropanoic acid,4-[2-hydroxy-3-[[2-[(4-morpholinylcarbonyl)amino]ethyl]amino]propoxy]-,(2,2-dimethyl-1,3-dioxolan-4-yl)methyl ester,[S-(R*,R*)]-;ONO 1101;Landiolol;2097506-25-5
-
Categories:
Active Pharmaceutical Ingredients > Circulatory System Drugs
-
CAS No:
Description
Landiolol was launched as iv infusion for the treatment of tachyarrhythmia during surgery. This structurally related derivative of esmolol can be synthesized in 3 linear steps from 3-(4-hydroxyphenyl)propionic acid by successive esterification followed by alkylation of the phenol function with (2S)-glycidyltosylate and opening of the resulting epoxide by the appropriate amine. Landiolol is an ultra short acting PI-adrenergic blocker more cardioselective (βI/β2 = 255) than esmolol (βi/β2 =
Landiolol is a member of morpholines.|Landiolol has been used in trials studying the treatment of Pharmacokinetics/Dynamics Study.
Landiolol Basic Attributes
509.59
509.59
1592732-453-0
62NWQ924LH
DTXSID3048605|DTXSID10158026
C - Cardiovascular system
Characteristics
128
0.80
White crystalline powder
1.2±0.1 g/cm3
125.4ºC
727.5±60.0 °C at 760 mmHg
393.8±32.9 °C
1.531
Safety Information
|Warning|H315 (100%): Causes skin irritation [Warning Skin corrosion/irritation]|P264, P280, P302+P352, P305+P351+P338, P321, P332+P313, P337+P313, and P362|The GHS information provided by 1 company from 1 notification to the ECHA C&L Inventory.
Drug Information
Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade. (See all compounds classified as Anti-Arrhythmia Agents.)|Drugs that bind to but do not activate beta-adrenergic receptors thereby blocking the actions of beta-adrenergic agonists. Adrenergic beta-antagonists are used for treatment of hypertension, cardiac arrhythmias, angina pectoris, glaucoma, migraine headaches, and anxiety. (See all compounds classified as Adrenergic beta-Antagonists.)
landiolol
Computed Properties
Molecular Weight:509.6
XLogP3:0.1
Hydrogen Bond Donor Count:3
Hydrogen Bond Acceptor Count:9
Rotatable Bond Count:14
Exact Mass:509.27371521
Monoisotopic Mass:509.27371521
Topological Polar Surface Area:128
Heavy Atom Count:36
Complexity:666
Defined Atom Stereocenter Count:2
Covalently-Bonded Unit Count:1
Compound Is Canonicalized:Yes
Learn More Other Chemicals
-
Landiolol hydrochloride
144481-98-1
-
Linoleic acid
60-33-3
-
Puerarin
3681-99-0
-
Sitagliptin Formula
486460-32-6
-
2-Butyl-4-chloro-5-formylimidazole Formula
83857-96-9
-
Barnidipine Formula
104713-75-9
-
Benidipine Structure
105979-17-7
-
Semotiadil Structure
116476-13-2
-
What is Tirofiban
144494-65-5
-
What is Niludipine
22609-73-0